Is mycophenolate mofetil really necessary in renal transplantation? A review of the MYSS follow-up study
- 28 August 2007
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Nephrology
- Vol. 3 (11), 602-603
- https://doi.org/10.1038/ncpneph0597
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trialThe Lancet, 2004
- Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deterioration1Transplantation, 2003
- MYCOPHENOLATE MOFETIL REDUCES LATE RENAL ALLOGRAFT LOSS INDEPENDENT OF ACUTE REJECTIONTransplantation, 2000
- MYCOPHENOLATE MOFETIL IN RENAL ALLOGRAFT RECIPIENTSTransplantation, 1997